Monument Capital Management Purchases Shares of 27,146 Cabot Co. (NYSE:CBT)

Monument Capital Management purchased a new position in shares of Cabot Co. (NYSE:CBT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 27,146 shares of the specialty chemicals company's stock, valued at approximately $2,267,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Arlington Trust Co LLC purchased a new position in Cabot in the fourth quarter valued at about $34,000. Milestone Investment Advisors LLC acquired a new position in Cabot during the 3rd quarter worth $79,000. Ronald Blue Trust Inc. increased its position in shares of Cabot by 460.7% in the 3rd quarter. Ronald Blue Trust Inc. now owns 1,895 shares of the specialty chemicals company's stock worth $127,000 after purchasing an additional 1,557 shares during the last quarter. NBC Securities Inc. acquired a new stake in shares of Cabot in the 3rd quarter valued at about $162,000. Finally, Blue Trust Inc. grew its stake in Cabot by 33.4% in the fourth quarter. Blue Trust Inc. now owns 2,527 shares of the specialty chemicals company's stock worth $211,000 after purchasing an additional 632 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.

Insider Activity

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of Cabot stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total value of $4,413,669.03. Following the transaction, the executive vice president now owns 97,201 shares in the company, valued at $7,767,331.91. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 3.07% of the company's stock.

Cabot Stock Performance

Cabot stock traded up $0.71 during mid-day trading on Monday, hitting $92.72. 216,273 shares of the company's stock traded hands, compared to its average volume of 308,258. The firm has a 50 day moving average price of $88.31 and a 200 day moving average price of $79.82. The company has a market cap of $5.14 billion, a PE ratio of 11.95, a price-to-earnings-growth ratio of 0.97 and a beta of 1.28. The company has a quick ratio of 1.30, a current ratio of 2.04 and a debt-to-equity ratio of 0.74. Cabot Co. has a one year low of $63.73 and a one year high of $98.34.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.07. Cabot had a net margin of 11.24% and a return on equity of 25.52%. The business had revenue of $958.00 million during the quarter, compared to analysts' expectations of $927.28 million. On average, equities analysts forecast that Cabot Co. will post 6.58 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CBT. UBS Group downgraded Cabot from a "buy" rating to a "neutral" rating and lowered their price target for the company from $90.00 to $87.00 in a report on Monday, January 8th. Mizuho began coverage on shares of Cabot in a report on Wednesday, March 27th. They set a "buy" rating and a $104.00 target price on the stock. StockNews.com lowered shares of Cabot from a "strong-buy" rating to a "buy" rating in a report on Wednesday, February 14th. Finally, Deutsche Bank Aktiengesellschaft cut Cabot from a "buy" rating to a "hold" rating and increased their price target for the stock from $88.00 to $95.00 in a research report on Thursday. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Cabot has a consensus rating of "Moderate Buy" and a consensus target price of $90.17.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.